Long-term survival in patients with advanced non–small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study
von Pawel, J., Bordoni, R., Satouchi, M., Fehrenbacher, L., Cobo, M., Han, J.Y., Hida, T., Moro-Sibilot, D., Conkling, P., Gandara, D.R., Rittmeyer, A., Gandhi, M., Yu, W., Matheny, C., Patel, H., Sandler, A., Ballinger, M., Kowanetz, M., Park, K.
Published in European journal of cancer (1990) (01.01.2019)
Published in European journal of cancer (1990) (01.01.2019)
Get full text
Journal Article
Hyperviscosity syndrome in IgA multiple myeloma
Halaseh, R M, Kaur, , S, Khanna, R, Conkling, P, Sarna, N, Magee, A
Published in QJM : An International Journal of Medicine (21.01.2022)
Published in QJM : An International Journal of Medicine (21.01.2022)
Get full text
Journal Article
Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors
Isakoff, S.J., Tabernero, J., Molife, L.R., Soria, J.-C., Cervantes, A., Vogelzang, N.J., Patel, M.R., Hussain, M., Baron, A., Argilés, G., Conkling, P.R., Sampath, D., Maslyar, D., Patel, P., Chan, W., Gendreau, S., Musib, L., Xu, N., Ma, H., Lin, K., Bendell, J.
Published in Annals of oncology (01.05.2020)
Published in Annals of oncology (01.05.2020)
Get full text
Journal Article
A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer
Doebele, R.C., Conkling, P., Traynor, A.M., Otterson, G.A., Zhao, Y., Wind, S., Stopfer, P., Kaiser, R., Camidge, D.R.
Published in Annals of oncology (01.08.2012)
Published in Annals of oncology (01.08.2012)
Get full text
Journal Article
Entrectinib in NTRK-fusion positive gastrointestinal cancers: integrated analysis of patients enrolled in three trials (STARTRK-2, STARTRK-1, and ALKA-372-001)
Siena, S., Demetri, G., Doebele, R., Chae, Y., Conkling, P., Garrido-Laguna, I., Garrido, P., Rolfo, C., Sigal, D., Eng, S., Simmons, B., Ye, C., Ciardiello, F.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
CC-486 (Oral Azacitidine) Induces Responses in Patients with Hematological Malignancies Who had Failed Prior Treatment with Injectable Hypomethylating Agents (HMAS)
Garcia-Manero, G, Savona, M.R, Gore, S.D, Scott, B.L, Cogle, C.R, Boyd, T, Conkling, P, Hetzer, J, Dong, Q, Kumar, K, Ukrainskyj, S.M, Skikne, B.S
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
99 CC-486 (ORAL AZACITIDINE) IN PATIENTS WITH INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS)-DEFINED HIGHER-RISK MYELODYSPLASTIC SYNDROMES (MDS)
Garcia-Manero, G, Savona, M.R, Gore, S.D, Cogle, C.R, Conkling, P, Hetzer, J, Dong, Q, Ukrainskyj, S.M, Skikne, B.S
Published in Leukemia research (01.04.2015)
Published in Leukemia research (01.04.2015)
Get full text
Journal Article
60 EXTENDED CC-486 (ORAL AZACITIDINE) DOSING IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS), ACUTE MYELOID LEUKEMIA (AML), OR CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML): SAFETY, TOLERABILITY, AND RESPONSE
Savona, M.R, Kolibaba, K, Conkling, P, Kingsley, E.C, Becerra, C, Morris, J.C, Rifkin, R.M, Laille, E, Kellerman, A, Ukrainskyj, S.M, Dong, Q, Skikne, B.S
Published in Leukemia research (01.04.2015)
Published in Leukemia research (01.04.2015)
Get full text
Journal Article
P-197 A study of gastric acid pH modulation on the pharmacokinetics of oral azacitidine (CC-486) in subjects with hematologic malignancies
Laille, E, Conkling, P, Kolibaba, K, Morris, J, Rifkin, R, Kingsley, E, Wang, X, Dong, Q, Kellerman, A, Skikne, B
Published in Leukemia research (01.05.2013)
Published in Leukemia research (01.05.2013)
Get full text
Journal Article
404 Phase I study of MEDI-575, a fully human monoclonal antibody targeting PDGFR-alpha in subjects with advanced solid tumors
Lechleider, R, Becerra, C, Liang, M, Narwal, R, Shi, L, Conkling, P, Galsky, M, Jotte, R, Wu, H, Vogelzang, N.J
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article
9148 Phase 1 study of the toll-like receptor 9 (TLR9) agonist, IMO-2055, combined with erlotinib (E) and bevacizumab (B) in patients (pts) with advanced or metastatic non-small cell lung cancer (NSCLC)
Smith, D.A, Conkling, P, Richards, D, Alemany, C, Boyd, T, Garbo, L, Wu, H, Wages, D, Bexon, A, Murphy, J
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
SO-32 Entrectinib in NTRK fusion-positive gastrointestinal cancers: Updated integrated analysis
Garrido-Laguna, I., Lonardi, S., Bazhenova, L., Peeters, M., Longo, F., Sigal, D., Conkling, P., Duffaud, F., Klingbiel, D., Bordogna, W., Ciardiello, F.
Published in Annals of oncology (01.06.2022)
Published in Annals of oncology (01.06.2022)
Get full text
Journal Article
1309P ARC-4: Efficacy and safety of AB928 plus carboplatin, pemetrexed and a PD-1 antibody in participants with metastatic non-small cell lung cancer (mNSCLC)
Spira, A., Conkling, P., Chaudhry, A., Colburn, D.E., Gilbert, H., Scharville, M., Gardner, O., Krishnan, K., Paoloni, M., Johnson, M.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
740P Anti-cytotoxic T-lymphocyte antigen-4 (CTLA 4) probody BMS-986249 ± nivolumab (NIVO) in patients (pts) with advanced cancers: Updated phase I results
Gutierrez, M., Friedman, C.F., Long, G.V., Ascierto, P.A., Melero, I., Richards, D., Bastos, B.R., Moreno Garcia, V., Uemura, M., Conkling, P., Corr, B.R., Kim, A.M., Zhu, L., Hammell, A., Perumal, D., Chouzy, A., Benavente, F., Awosemo, O., Hannah, A., Le, D.T.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
95P Understanding the real-world (RW) impact of time between treatment regimens on clinical outcomes in patients with metastatic NSCLC previously treated with immunotherapy (IO) in the US community oncology setting
Spira, A., Korytowsky, B., Gao, S., Wilson, T., Osterland, A., Shi, J., Conkling, P.
Published in ESMO open (01.03.2024)
Published in ESMO open (01.03.2024)
Get full text
Journal Article
O-024Entrectinib in NTRK-fusion positive gastrointestinal cancers: integrated analysis of patients enrolled in three trials (STARTRK-2, STARTRK-1, and ALKA-372-001)
Siena, S, Demetri, G, Doebele, R, Chae, Y, Conkling, P, Garrido-Laguna, I, Garrido, P, Rolfo, C, Sigal, D, Eng, S, Simmons, B, Ye, C, Ciardiello, F
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Sphingosine inhibits monocyte tissue factor-initiated coagulation by altering factor VII binding
Conkling, P R, Patton, K L, Hannun, Y A, Greenberg, C S, Weinberg, J B
Published in The Journal of biological chemistry (05.11.1989)
Published in The Journal of biological chemistry (05.11.1989)
Get full text
Journal Article
O-3 Efficacy and safety of entrectinib in NTRK fusion-positive gastrointestinal cancers: Updated integrated analysis of three clinical trials (STARTRK-2, STARTRK-1 and ALKA-372-001)
Patel, M., Siena, S., Demetri, G., Doebele, R., Chae, Y., Conkling, P., Garrido-Laguna, I., Longo, F., Rolfo, C., Sigal, D., Drilon, A., Liu, S., Goto, K., Bazhenova, L., Lonardi, S., Ciardiello, F., Huang, X., Osborne, S., Aziez, A., de Braud, F.
Published in Annals of oncology (01.07.2020)
Published in Annals of oncology (01.07.2020)
Get full text
Journal Article